APA

Kröger N., Bornhäuser M., Stelljes M., Pichlmeier U., Trenschel R., Schmid C., Arnold R., Martin H., Heinzelmann M., Wolschke C., Meyer R. G., Bethge W., Kobbe G., Ayuk F., Gökbuget N., Hölzer D., Zander A. & Beelen D. (20160912). Allogeneic stem cell transplantation after conditioning with treosulfan, etoposide and cyclophosphamide for patients with ALL: a phase II-study on behalf of the German Cooperative Transplant Study Group and ALL Study Group (GMALL). : Bone marrow transplantation.

Chicago

Kröger N, Bornhäuser M, Stelljes M, Pichlmeier U, Trenschel R, Schmid C, Arnold R, Martin H, Heinzelmann M, Wolschke C, Meyer R G, Bethge W, Kobbe G, Ayuk F, Gökbuget N, Hölzer D, Zander A and Beelen D. 20160912. Allogeneic stem cell transplantation after conditioning with treosulfan, etoposide and cyclophosphamide for patients with ALL: a phase II-study on behalf of the German Cooperative Transplant Study Group and ALL Study Group (GMALL). : Bone marrow transplantation.

Harvard

Kröger N., Bornhäuser M., Stelljes M., Pichlmeier U., Trenschel R., Schmid C., Arnold R., Martin H., Heinzelmann M., Wolschke C., Meyer R. G., Bethge W., Kobbe G., Ayuk F., Gökbuget N., Hölzer D., Zander A. and Beelen D. (20160912). Allogeneic stem cell transplantation after conditioning with treosulfan, etoposide and cyclophosphamide for patients with ALL: a phase II-study on behalf of the German Cooperative Transplant Study Group and ALL Study Group (GMALL). : Bone marrow transplantation.

MLA

Kröger N, Bornhäuser M, Stelljes M, Pichlmeier U, Trenschel R, Schmid C, Arnold R, Martin H, Heinzelmann M, Wolschke C, Meyer R G, Bethge W, Kobbe G, Ayuk F, Gökbuget N, Hölzer D, Zander A and Beelen D. Allogeneic stem cell transplantation after conditioning with treosulfan, etoposide and cyclophosphamide for patients with ALL: a phase II-study on behalf of the German Cooperative Transplant Study Group and ALL Study Group (GMALL). : Bone marrow transplantation. 20160912.